Literature DB >> 23769183

Uterine sarcomas 2013.

Gregory Sutton1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23769183     DOI： 10.1016/j.ygyno.2013.05.015

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  3 in total

1.  Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcoma.

Authors:  Koji Matsuo; Kohei Omatsu; Malcolm S Ross; Marian S Johnson; Mayu Yunokawa; Merieme M Klobocista; Dwight D Im; Stephen H Bush; Yutaka Ueda; Tadao Takano; Erin A Blake; Kosei Hasegawa; Tsukasa Baba; Masako Shida; Shinya Satoh; Takuhei Yokoyama; Hiroko Machida; Sosuke Adachi; Yuji Ikeda; Keita Iwasaki; Takahito M Miyake; Shiori Yanai; Masato Nishimura; Tadayoshi Nagano; Munetaka Takekuma; Satoshi Takeuchi; Tanja Pejovic; Mian Mk Shahzad; Frederick R Ueland; Joseph L Kelley; Lynda D Roman
Journal:  Gynecol Oncol       Date:  2017-02-16       Impact factor: 5.482

2.  MMPs and angiogenesis affect the metastatic potential of a human vulvar leiomyosarcoma cell line.

Authors:  Carlotta Alias; Laura Rocchi; Domenico Ribatti; Stefano Caraffi; Alessandra D'Angelo; Roberto Perris; Domenica Mangieri
Journal:  J Cell Mol Med       Date:  2015-05-22       Impact factor: 5.310

3.  Trends of uterine carcinosarcoma in the United States.

Authors:  Koji Matsuo; Malcolm S Ross; Hiroko Machida; Erin A Blake; Lynda D Roman
Journal:  J Gynecol Oncol       Date:  2018-01-05       Impact factor: 4.401
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.